S&P 500   3,385.85 (+0.46%)
DOW   29,309.38 (+0.26%)
QQQ   236.75 (+0.86%)
AAPL   323.20 (+1.32%)
FB   217.05 (-0.34%)
MSFT   186.99 (-0.13%)
GOOGL   1,528.78 (+0.61%)
AMZN   2,176.04 (+0.94%)
CGC   21.63 (-1.41%)
NVDA   309.92 (+4.50%)
BABA   221.71 (+0.54%)
MU   58.76 (+1.75%)
TSLA   929.00 (+8.22%)
AMD   58.55 (+2.92%)
T   38.28 (+0.05%)
F   8.05 (-0.12%)
NFLX   390.00 (+0.57%)
PRI   136.07 (+0.33%)
BAC   34.72 (+1.31%)
DIS   140.45 (+0.94%)
GILD   67.07 (+0.09%)
S&P 500   3,385.85 (+0.46%)
DOW   29,309.38 (+0.26%)
QQQ   236.75 (+0.86%)
AAPL   323.20 (+1.32%)
FB   217.05 (-0.34%)
MSFT   186.99 (-0.13%)
GOOGL   1,528.78 (+0.61%)
AMZN   2,176.04 (+0.94%)
CGC   21.63 (-1.41%)
NVDA   309.92 (+4.50%)
BABA   221.71 (+0.54%)
MU   58.76 (+1.75%)
TSLA   929.00 (+8.22%)
AMD   58.55 (+2.92%)
T   38.28 (+0.05%)
F   8.05 (-0.12%)
NFLX   390.00 (+0.57%)
PRI   136.07 (+0.33%)
BAC   34.72 (+1.31%)
DIS   140.45 (+0.94%)
GILD   67.07 (+0.09%)
S&P 500   3,385.85 (+0.46%)
DOW   29,309.38 (+0.26%)
QQQ   236.75 (+0.86%)
AAPL   323.20 (+1.32%)
FB   217.05 (-0.34%)
MSFT   186.99 (-0.13%)
GOOGL   1,528.78 (+0.61%)
AMZN   2,176.04 (+0.94%)
CGC   21.63 (-1.41%)
NVDA   309.92 (+4.50%)
BABA   221.71 (+0.54%)
MU   58.76 (+1.75%)
TSLA   929.00 (+8.22%)
AMD   58.55 (+2.92%)
T   38.28 (+0.05%)
F   8.05 (-0.12%)
NFLX   390.00 (+0.57%)
PRI   136.07 (+0.33%)
BAC   34.72 (+1.31%)
DIS   140.45 (+0.94%)
GILD   67.07 (+0.09%)
S&P 500   3,385.85 (+0.46%)
DOW   29,309.38 (+0.26%)
QQQ   236.75 (+0.86%)
AAPL   323.20 (+1.32%)
FB   217.05 (-0.34%)
MSFT   186.99 (-0.13%)
GOOGL   1,528.78 (+0.61%)
AMZN   2,176.04 (+0.94%)
CGC   21.63 (-1.41%)
NVDA   309.92 (+4.50%)
BABA   221.71 (+0.54%)
MU   58.76 (+1.75%)
TSLA   929.00 (+8.22%)
AMD   58.55 (+2.92%)
T   38.28 (+0.05%)
F   8.05 (-0.12%)
NFLX   390.00 (+0.57%)
PRI   136.07 (+0.33%)
BAC   34.72 (+1.31%)
DIS   140.45 (+0.94%)
GILD   67.07 (+0.09%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 IntrexonSorrento TherapeuticsAuxly Cannabis GroupNational ResearchSTARPHARMA HOLD/S
SymbolNASDAQ:XONNASDAQ:SRNEOTCMKTS:CBWTFNASDAQ:NRCOTCMKTS:SPHRY
Price Information
Current Price$4.42$2.65$0.42$69.00$7.90
52 Week RangeHoldBuyN/AHoldN/A
Analyst Ratings
Consensus RecommendationHoldBuyN/AHoldN/A
Consensus Price Target$19.67$21.00N/AN/AN/A
% Upside from Price Target344.95% upside692.33% upsideN/AN/AN/A
Trade Information
Market Cap$719.06 million$456.41 million$268.19 million$1.72 billion$290.15 million
Beta2.363.040.530.771.5
Average Volume1,421,6004,068,075776,10224,3441,250
Sales & Book Value
Annual Revenue$160.57 million$21.19 million$580,000.00$127.98 million$3.79 million
Price / Sales4.4820.99462.4013.4477.54
CashflowN/AN/AN/A$1.43 per shareN/A
Price / CashN/AN/AN/A48.13N/A
Book Value$2.76 per share$1.70 per share$0.41 per share$0.77 per share$1.11 per share
Price / Book1.601.561.0289.617.12
Profitability
Net Income$-509,340,000.00$-203,540,000.00$-51,680,000.00$32.41 million$-7,970,000.00
EPS($1.37)($1.92)N/AN/AN/A
Trailing P/E RatioN/AN/AN/A54.760.00
Forward P/E RatioN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-393.13%-1,101.69%-1,316.81%25.32%N/A
Return on Equity (ROE)-45.51%-193.12%-29.20%125.15%N/A
Return on Assets (ROA)-20.69%-31.37%-18.87%30.72%N/A
Dividend
Annual PayoutN/AN/AN/A$0.84N/A
Dividend YieldN/AN/AN/A1.22%N/A
Three-Year Dividend GrowthN/AN/AN/A28.06%N/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/A5 YearsN/A
Debt
Debt-to-Equity Ratio0.97%43.15%0.30%1.07%N/A
Current Ratio1.92%0.60%1.77%0.69%N/A
Quick Ratio1.71%0.56%1.46%0.69%N/A
Ownership Information
Institutional Ownership Percentage76.41%14.55%N/A39.80%N/A
Insider Ownership Percentage44.00%4.80%N/A4.50%N/A
Miscellaneous
EmployeesN/A382N/AN/AN/A
Shares Outstanding162.68 million167.80 million638.25 million24.92 million37.20 million
Next Earnings Date2/27/2020 (Estimated)3/20/2020 (Estimated)4/3/2020 (Estimated)5/5/2020 (Estimated)N/A
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel